Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram

The purpose of this study was to investigate the impact of a family history of malignant tumor on the prognosis of patients with gastric cancer and develop a nomogram that incorporates a family history of malignant tumor to predict overall survival (OS) in patients with gastric cancer to aid clinicians and patients in decision making. Four hundred eighty-eight patients with gastric cancer undergoing radical gastrectomy in our center were included and randomly split into a training set (n = 350) and a validation set (n = 138) at a ratio of 7:3. Cox univariate regression analysis was used to evaluate the influence of clinicopathological characteristics and family history of malignant tumors on their prognosis, and variables were screened by multivariate Cox regression analysis and consensus on clinical evidence. A nomogram was constructed for OS based on the filtered variables, and the C-index, receiver operating characteristic curve (ROC curve), and calibration curve were used to validate the nomogram and decision curve analysis curve (DCA curve) was used for clinical practicality assessment. Six variables related to OS, including the pathological differentiation degree, Lauren type, infiltration depth, lymph node metastasis, tumor deposit, and family history of malignant tumor, were screened to construct a nomogram. The nomogram developed in this study performed well in the training set and the validation set, with C-index of 0.776 and 0.757, and the area under the ROC curve(AUC) for predicting 1-, 3-, and 5-year survival rates are 0.838, 0.850, 0.820 and 0.754, 0.789, 0.808, respectively. The calibration curve shows that the estimated death risk of the nomogram in the 2 data sets is very close to the actual death risk. The net benefits of nomogram-guided prediction of patient survival at 1-, 3-, and 5 years were demonstrated by the DCA curves, which showed high clinical practicability. Family history of malignant tumors is an independent risk factor affecting the prognosis of patients with gastric cancer. The nomogram developed in this research can be used as an important tool to predict the prognosis of gastric cancer patients with family history data.

[1]  X. Zou,et al.  Differential prognostic implications of gastric adenocarcinoma based on Lauren’s classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study , 2021, Annals of translational medicine.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Irene Abad,et al.  "From Lauren's diffuse gastric cancer to WHO's poorly cohesive carcinoma." Clinicopathological and prognostic characteristics. , 2020 .

[4]  M. Terashima,et al.  Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Xiangqian Guo,et al.  The Application of Deep Learning in Cancer Prognosis Prediction , 2020, Cancers.

[6]  I. Bedrosian,et al.  Importance of family history and indications for genetic testing , 2019, The breast journal.

[7]  Zhimeng Xu,et al.  Tumor deposit indicates worse prognosis than metastatic lymph node in gastric cancer: a propensity score matching study. , 2019, Annals of translational medicine.

[8]  Andrew J. Vickers,et al.  A simple, step-by-step guide to interpreting decision curve analysis , 2019, Diagnostic and Prognostic Research.

[9]  H. Liang,et al.  Impact of extranodal tumor deposits on prognosis and N stage in gastric cancer. , 2019, Surgery.

[10]  Yue-xiang Liang,et al.  Tumor Size Improves the Accuracy of the Prognostic Prediction of Lymph Node-Negative Gastric Cancer. , 2019, The Journal of surgical research.

[11]  E. Jung,et al.  Nomogram for predicting gastric cancer recurrence using biomarker gene expression. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  H. Hampel,et al.  Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[13]  Y. K. Park,et al.  Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer , 2017, Journal of gastric cancer.

[14]  Wei Luo,et al.  Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View , 2016, Journal of medical Internet research.

[15]  K. Akazawa,et al.  Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery. , 2016, International journal of surgery.

[16]  L. Wood,et al.  Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis , 2016, Journal of Gastrointestinal Surgery.

[17]  Z. Long,et al.  Prognostic significance of cancer family history for patients with gastric cancer: a single center experience from China , 2016, Oncotarget.

[18]  Jeffrey W. Clark,et al.  Familial Gastric Cancers. , 2015, The oncologist.

[19]  Mithat Gonen,et al.  Nomograms in oncology: more than meets the eye. , 2015, The Lancet. Oncology.

[20]  Y. Nishino,et al.  Family history, body mass index and survival in Japanese patients with stomach cancer: a prospective study , 2015, International journal of cancer.

[21]  Muh-Hwa Yang,et al.  Clinicopathological Variation of Lauren Classification in Gastric Cancer , 2015, Pathology & Oncology Research.

[22]  W. Rubinstein,et al.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Jin Hwa Kim,et al.  Family history and survival of patients with gastric cancer: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[24]  L. Bernstein,et al.  Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case–control study , 2014, BMC Cancer.

[25]  Chang-ming Huang,et al.  Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. , 2013, Surgical oncology.

[26]  A. Meloni-Ehrig,et al.  Gastric cancer: Classification, histology and application of molecular pathology. , 2012, Journal of gastrointestinal oncology.

[27]  Chang-ming Huang,et al.  Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center Study of 724 Patients , 2012, Journal of oncology.

[28]  I. Choi,et al.  Association of family history with cancer recurrence and survival in patients with gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Sang Min Park,et al.  Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. , 2011, World journal of gastroenterology.

[30]  P. Lu,et al.  Family history of cancer in Chinese gastric cancer patients , 2010 .

[31]  S. Narod,et al.  Family history and the risk of gastric cancer , 2009, British Journal of Cancer.

[32]  N. Hu,et al.  Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China , 2009, BMC Cancer.

[33]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Wolff,et al.  APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer , 2007, Molecular Cancer Research.

[35]  R. Sinha,et al.  Opportunities for cancer epidemiology in developing countries , 2004, Nature Reviews Cancer.

[36]  S. Kitano,et al.  Pathology and prognosis of gastric carcinoma , 2000, Cancer.